Redox Raises $33M in Series C Funding

redoxRedox, a Madison, Wis.-based company that allows healthcare providers and software vendors to share data digitally, closed a $33m Series C funding round.

The round was led by global investment firm Battery Ventures with participation from existing investors .406 Ventures, RRE Ventures, and Intermountain Ventures. As part of the transaction, Battery General Partner Chelsea Stoner, will join the Redox board.

Led by co-founder and CEO Luke Bonney, Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare.
With Redox, software developers enable easy access through an intuitive and standardized application programming interface (API). Its vendor-agnostic approach allows messages to be sent or received securely in any format associated with an organization’s electronic health record (EHR).

Over 450 healthcare providers and hundreds of cloud-based applications use the Redox Interoperability Platform to exchange information with partners. Among them, AdventHealth, Atrium Health, Brigham & Women’s Hospital, Clarify Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar.




Join the discussion